The new multiplex cytokine and cytotoxicity assays as a part of the Opto Cell Therapy Development 1.0 workflow will help users of the Berkeley ... Apr 28
The T Cell Receptor Sequencing Kit (TCRseq Kit) allows users of Berkeley Lights platforms to more efficiently identify, recover, and sequence T cells of interest ... Mar 06
Berkeley Lights' proprietary technology, the Beacon optofluidic platform, is currently used by researchers across three continents—the U.S., China, and Australia—to help them ... Mar 02
-Advertisements-